109054 ⎘
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor; Recombinant DNA-technology; DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides against enzymes
Molecules of the card-related protein family and uses thereof
#3302SiRNA-mediated inhibition of doublecortin and Ca2+/calmodulin-dependent kinase-like-1
#3303Aberrant expression of CKS1 and CKS2 and uses thereof
#3304Oligonucleotides comprising a non-phosphate backbone linkage
#3305Antisense oligonucleotide against human acetylcholinesterase (AChE) and uses thereof
#3306RNAi-Mediated Inhibition of RHO Kinase for Treatment of Ocular Disorders
#3307siRNA targeting inner centromere protein antigens (INCENP)
#3308USP47 inhibtors and methods to induce apoptosis
#3309Method of inhibiting human Trabid
#3310ANTISENSE OLIGONUCLEOTIDES AGAINST ACETYLCHOLINESTERASE FOR TREATING INFLAMMATORY DISEASES
#3311Reprogramming a cell by inducing a pluripotent gene through use of an HDAC modulator
#3312TARGETING TNF-alpha CONVERTING ENZYME(TACE)- DEPENDENT GROWTH FACTOR SHEDDING IN CANCER THERAPY
#3313MODULATION OF TUDOR-SN EXPRESSION
#3314Compositions and methods for inhibiting the synthesis or expression of MMP-1
#3315Reprogramming a cell by inducing a pluripotent gene through RNA interference
#3316Kit for detection of telomerase reverse transcriptase nucleic acids
#3317Methods of inhibiting multiple cytochrome P450 genes with siRNA
#3318Conjugates and compositions for cellular delivery
#3319Compositions and methods for inhibiting expression of factor VII gene
#3320Means and methods of using a NADPH oxidase inhibitor for the treatment of hearing loss and phantom hearing
#3321Inhibitors of mammalian hdac 11 useful for treating hdac 11 mediated disorders
#3322Reprogramming a Cell by Inducing a Pluripotent Gene Through Use of a Small Molecule Modulator
#3323dsRNA compositions and methods for treating HPV infection
#3324Antisense oligonucleotides against protein kinase isoforms alpha, beta and gamma
#3325RNA INTERFERENCE MEDIATED INHIBITION OF PROTEIN TYROSINE PHOSPHATASE-1B (PTP-1B) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
#3326Methods and Compositions for Seprase Inactivation
#3327RNA Interference Mediated Inhibition of Protein Tyrosine Phosphatase-1B (PTP-1B) Gene Expression Using Short Interfering RNA
#3328Methyltransferases and Their Uses
#3329USE OF FRUCTOSE-BASED THERAPIES FOR THE TREATMENT OF CANCER
#3330Inhibition of tumor growth and invasion by anti matrix metalloproteinase DNAzymes
#3331Methods for Reducing Body Fat and Increasing Lean Body Mass by Reducing Stearoyl-COA Desaturase 1 Activity
#3332Compositions and methods for therapy and diagnosis of cancer
#3333MODULATION OF LMW-PTPASE EXPRESSION
#3334Composition for suppressing the expression of fucosyltransferase
#3335Method of cancer treatment using siRNA silencing
#3336ADAM10 and its uses related to infection
#3337METHOD FOR TREATING CANCERS WITH INCREASED RAS SIGNALING
#3338Use of cis-epoxyeicosatrienoic acids and inhibitors of soluble epoxide hydrolase to reduce cardiomyopathy
#3339Cancer-cell-specific cell proliferation inhibitors
#3340Methods and compositions for vitamin K epoxide reductase
#3341Methods and compositions for vitamin K epoxide reductase
#3342Methods of modifying insulin signaling using biliverdin reductase
#3343Methods and compositions for regulating cell cycle checkpoints
#3344Oligonucleotides with alternating segments of locked and non-locked nucleotides
#3345Anti-sense nucleic acid derived from organism
#3346Pyruvate dehydrogenase kinases as therapeutic targets for cancer and ischemic diseases
#3347NOVEL USE OF UBIQUITIN C-TERMINAL HYDROLASE-L1
#3348Method of producing antibodies with improved function
#3349DUB3 as a Cancer Therapy Target
#3350siRNA targeting cyclin-dependent kinase 4 (CDK4)
#3351Retrotransposon Inhibition in Therapy
#3352Compositions and methods for RNA interference with sialidase expression and uses thereof
#3353GENE THERAPY FOR CANCER USING SMALL INTERFERING RNA SPECIFIC TO ANT2 AND A METHOD TO OVERCOME TOLERANCE TO ANTITUMOR AGENT
#3354Gene and polypeptide relating to breast cancer
#3355si-RNA-mediated gene silencing technology to inhibit tyrosinase and reduce pigmentation
#33562'-Modified Oligonucleotides
#3357Modified short interfering RNA
#3358TAK1-D mediated induction of cell death in human cancer cells by specific sequence short double-stranded RNAS
#3359RNA antagonist compounds for the modulation of PIK3CA expression
#3360RNA interference mediated inhibition of hypoxia inducible factor 1 (HIF1) gene expression using short interfering nucleic acid (siNA)
#3361Interfering RNA molecules
#3362SiRNA DELIVERY INTO MAMMALIAN NERVE CELLS
#3363Transgenic plants modified for reduced cadmium transport, derivative products, and related methods
#3364siRNA targeting phosphatases
#3365LNA antagonists targeting the androgen receptor
#3366Methods and compositions for treating cellular proliferative diseases
#3367DETECTION OF PKC-IOTA AS A BIOMARKER FOR BRAIN TUMORIGENESIS
#3368Arginase II: a target for the prevention of atherosclerosis
#3369BGL7 beta-glucosidase and nucleic acids encoding the same
#3370METHOD FOR DEMONSTRATING PRESENCE OR ABSENCE OF MARKERS ASSOCIATED WITH THE PRESENCE AND/OR THE CHEMOSENSITIVITY OF TUMORS
#3371CNS-tumor treatment method and composition
#3372Use of fructose-based compounds for the diagnosis of cancer
#3373Wound healing
#3374Hunk, a snfi-related kinase essential for mammary tumor metastasis
#3375Molecular targets and compounds, and methods to identify the same, useful in the treatment of joint degenerative and inflammatory diseases
#3376EGVII endoglucanase and nucleic acids encoding the same
#3377Inhibitors of ribonucleotide reductase subunit 2 and uses thereof
#3378Negative immunomodulation of immune responses by ERp5
#3379Gene therapy and pharmaceutical composition for prevention and treatment of lung cancer
#3380siRNA targeting myeloid cell leukemia sequence 1
#3381siRNA targeting tumor necrosis factor receptor superfamily member 1A
#3382COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING BRAIN CANCER AND IDENTIFYING NEURAL STEM CELLS
#3383Novel siRNAS and methods of use thereof
#3384COMPOSITIONS COMPRISING HDAC INHIBITORS AND METHODS OF THEIR USE IN RESTORING STEM CELL FUNCTION AND PREVENTING HEART FAILURE
#3385DBAIT and uses thereof
#3386MODULATION OF ENDOTHELIAL LIPASE EXPRESSION
#3387COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING ASTHMA OR OTHER ALLERGIC OR INFLAMMATORY DISEASES
#3388RNA INTERFERENCE MEDIATED INHIBITION OF STROMAL CELL-DERIVED FACTOR-1 (SDF-1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
#3389RNA interference mediated inhibition of hepatitis C virus (HCV) gene expression using short interfering nucleic acid (siNA)
#3390Novel siRNAS and methods of use thereof
#3391METHODS AND COMPOSITIONS FOR MODULATING FOXO1 ACTIVITY AND INSULIN SIGNALING
#3392SiRNA targeting KRAS
#3393RNA interference mediated inhibition of telomerase gene expression using short interfering nucleic acid (siNA)
#3394RNA interference mediated treatment of Alzheimer's disease using short interfering nucleic acid (siNA)
#3395SiRNA silencing of genes expressed in cancer
#3396Composition comprising double stranded RNA that inhibits expression of NEU3 and method for treating cancer
#3397Application of RNA Interference Targeting DHFR Gene, to Cell for Protein Production
#3398Cell transfecting formulations of small interfering RNA related compositions and methods of making and use
#3399Kinase suppressor of Ras inactivation for therapy of Ras mediated tumorigenesis
#3400Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)
#3401Breast cancer related gene ZNFN3A1
#3402Pancreatic cancer targets and uses thereof
#3403Methods and compositions for silencing genes without inducing toxicity
#3404RNA Interference Mediated Inhibition of Acetyl-CoA-Carboxylase Gene Expression Using Short Interfering Nucleic Acid (siNA)
#3405RNA Interference Mediated Inhibition of Cyclic Nucleotide Type 4 Phosphodiesterase (PDE4B) Gene Expression Using Short Interfering Nucleic Acid (siNA)
#3406Methods and Compositions for Modulating Body Weight and for Treating Weight Disorders and Related Diseases
#3407PROSTATE CARCINOGENESIS PREDICTOR
#3408Antisense modulation of PTP1B expression
#3409INHIBITION OF THE SH2-DOMAIN CONTAINING PROTEIN TYR-PHOSPHATASE, SHP-1, TO ENHANCE VACCINES
#3410Detection of mutations in a gene associated with resistance to viral infection, OAS1
#3411Compositions for Bacterial Mediated Gene Silencing and Methods of Using the Same
#3412siRNA targeting nucleoporin 62kDa (Nup62)
#3413Antisense Oligonucleotides Directed to Ribonucleotide Reductase R2 and uses Thereof in the Treatment of Cancer
#3414Novel Gene Therapy Approach For Treating The Metabolic Disorder Obesity
#3415Modulation of diacylglycerol acyltransferase 1 expression
#3416Methods and compositions for the treatment of eye disorders with increased intraocular pressure
#3417Methods and compositions for the treatment of eye disorders with increased intraocular pressure
#3418EML4-ALK fusion gene
#3419RNA interference mediated inhibition of Stearoyl-CoA desaturase (SCD) gene expression using short interfering nucelic acid (siNA)
#3420RNA interference mediated inhibition of MYC and/or MYB gene expression using short interfering nucleic acid (siNA)
#3421Methods and compositions for the treatment of eye disorders with increased intraocular pressure
#3422Methods and compositions for the treatment of eye disorders with increased intraocular pressure
#3423Methods and compositions for the treatment of eye disorders with increased intraocular pressure
#3424Methods and compositions for the treatment of eye disorders with increased intraocular pressure
#3425Modulation of line-1 reverse transcriptase
#3426Technology for the Preparation of Microparticles
#3427Treatment of neurodegenerative diseases by the use of scd4 inhibitors
#3428Vitamin K Epoxide Recycling Polypeptide VKORC1, a Therapeutic Target of Coumarin and Their Derivatives
#3429RNA interference mediated inhibition of checkpoint kinase-1 (CHK-1) gene expression using short interfering nucleic acid (siNA)
#3430Compositions and methods to stack multiple nucleotide sequences of interest in the genome of a plant
#3431Enhanced retinal delivery of a nucleic acid through iontophoresis
#3432siRNA targeting transducin (beta)-like 3 (TBL3)
#3433Oligonucleotide analogs having cationic intersubunit linkages
#3434siRNA targeting TATA box binding protein (TBP)-associated factor (TAF1)
#3435DRUG FOR PREVENTING AND TREATING ATHEROSCLEROSIS
#3436Diagnosis, prevention and treatment of cancer
#3437Double-stranded RNA oligonucleotides which inhibit tyrosinase expression
#3438INHIBITING DNA POLYMERASE BETA TO ENHANCE EFFICACY OF ANTICANCER AGENTS
#3439METHODS AND COMPOSITIONS FOR NUCLEIC ACID TRANSFER INTO CELLS
#3440siRNA targeting inner centromere protein antigens (INCENP)
#3441METHOD AND COMPOSITION FOR REDUCING THE EXPRESSION OF ROCK-II
#3442Compositions and methods of treating cancer
#3443Devices, systems and methods for improving memory and/or cognitive function through brain delivery of siRNA
#3444Compositions and their uses directed to diacylglycerol acyltransferase 1
#3445COMPOSITIONS AND METHODS OF SPHINGOSINE KINASE INHIBITORS FOR USE THEREOF IN CANCER THERAPY
#3446Telomerase RNA Subunit and Methods of Use Thereof
#3447Inhibitors of prolyl-hydroxylase-1 for the treatment of skeletal muscle degeneration
#3448Methods and compositions for treating gain-of-function disorders using RNA interference
#3449RNAi-RELATED INHIBITION OF TNFa SIGNALING PATHWAY FOR TREATMENT OF MACULAR EDEMA
#3450RNAi-RELATED INHIBITION OF TNFalpha SIGNALING PATHWAY FOR TREATMENT OF OCULAR ANGIOGENESIS
#3451Modulation of line-1 reverse transcriptase
#3452RNAi-RELATED INHIBITION OF TNFa SIGNALING PATHWAY FOR TREATMENT OF GLAUCOMA
#3453siRNA targeting 1-acylglycerol-3-phosphate O-acyltransferase 2 (AGPAT2)
#3454Oligonucleotide compositions and methods for treating disease including inflammatory conditions
#3455RNA interference in respiratory epithelial cells
#3456Cancer cell-specific apoptosis-inducing agents that target chromosome stabilization-associated genes
#3457Compositions and methods for studying and treating inflammatory diseases and disorders
#3458Double-Stranded Oligonucleotides
#3459INHIBITION OF BRAIN ENZYMES INVOLVED IN CEREBRAL AMYLOID ANGIOPATHY AND MACULAR DEGENERATION
#3460RNAi-MEDIATED INHIBITIN OF HTRA1 FOR TREATMENT OF MACULAR DEGENERATION
#3461Delivery of siRNA by neutral lipid compositions
#3462Use of cytochrome P450 reductase as insecticidal target
#3463Methods of diagnosing pre-eclampsia or eclampsia
#3464siRNA targeting protein kinase N-3 (PKN-3)
#3465INTRANASAL DELIVERY OF NUCLEIC ACID MOLECULES
#3466Antisense oligonucleotides against thymidylate synthase
#3467Methods and compositions for regulating HDAC4 activity
#3468Antagonist of the oncogenic activity of the protein MDM2, and use thereof in the treatment of cancers
#3469Use of Sirnas in Organ Storage/Reperfusion Solutions
#3470Antisense Oligonucleotides Directed to Ribonucleotide Reducatase R2 and Uses Thereof in Combination Therapies for the Treatment of Cancer
#3471siRNA targeting proprotein convertase subtilisin/kexin type 9 (PCSK9)
#3472siRNA targeting vascular endothelial growth factor receptor 1 (VEGFR1)
#3473Alpha-Synuclein Kinase
#3474Method For Treating Huntington's Disease by Inhibiting Dephosphorylation of Huntingtin at S421
#3475Bacterially derived intact minicells that encompass plasmid free functional nucleic acid for in vivo delivery to mammalian cells
#3476FC gamma RIIA-specific nucleic acid interference
#3477siRNA targeting protein tyrosine phosphatase-1B (PTP1B)
#3478siRNA targeting casitas B cell lymphoma-B (CBL-B)
#3479NUCLEIC ACID COMPOUNDS FOR INHIBITING AKT GENE EXPRESSION AND USES THEREOF
#3480Pharmaceutical Composition Containing Meltrin Antagonist
#3481Oligoribonucleotides and methods of use thereof for treatment of fibrotic conditions and other diseases
#3482NUCLEIC ACID COMPOUNDS FOR INHIBITING ERBB GENE EXPRESSION AND USES THEREOF
#3483Antisense oligonucleotides against cPLA, compositions and uses thereof
#3484System for producing terpenoids in plants
#3485Compositions and their uses directed to PTPRU
#3486Oligoribonucleotide Inhibiting Growth of Tumor Cells and Method Therefor
#3487Method for eliciting an immune response to human telomerase reverse transcriptase
#3488ALK protein tyrosine kinase, cells and methods embodying and using same
#3489Methods for treating cancer targeting transglutaminase
#3490E2epf Ubiquitin Carrier Protein-Von Hippel-Lindau Interaction and Uses Thereof
#3491COMPOSITIONS AND METHODS OF SPHINGOSINE KINASE INHIBITORS IN RADIATION THERAPY OF VARIOUS CANCERS
#3492METHODS AND COMPOSITIONS FOR ENHANCING DELIVERY OF DOUBLE-STRANDED RNA OR A DOUBLE-STRANDED HYBRID NUCLEIC ACID TO REGULATE GENE EXPRESSION IN MAMMALIAN CELLS
#3493pRNA chimera
#3494Organic Compounds
#3495Method for identifying compounds for treatment of pain
#3496ANTISENSE OLIGONUCLEOTIDE STRATEGIES FOR THE ENHANCEMENT OF CANCER THERAPIES
#3497Compositions and methods for the modulation of JNK proteins
#3498Regulation of mink in thymocytes and T lymphocytes
#3499Modified polynucleotides for reducing off-target effects in RNA interference
#3500Inhibiting Gene Expression with dsRNA
#3501Nucleotide-Cochleate Compositions And Methods Of Use
#3502Identification of genetic alterations that modulate drug sensitivity in cancer treatments
#3503Oligonucleotide-containing pharmacological compositions and their use
#3504Mycobacterial peptide deformylase
#3505siRNA targeting ribonucleotide reductase M2 polypeptide (RRM2 or RNR-R2)
#3506Dampening Humoral and Innate Immunity by Inhibition of Ppgalnact-1
#3507Cell-Based Rna Interference and Related Methods and Compositions
#3508siRNA targeting cystic fibrosis transmembrane conductance regulator (CFTR)
#3509Inhibiting Gene Expression with dsRNA
#3510Modulation of Wrn-Mediated Telomere-Initiated Cell Signaling
#3511Products and Methods Related to Mono-Methyl Branched-Chain Fatty Acids
#3512Aptamer-mediated intracellular delivery of oligonucleotides
#3513Histone deacetylase inhibitor and use thereof
#3514NOVEL C. ELEGANS P21-ACTIVATED KINASE (PAK) GENE AND ASSOCIATED LOSS-OF-FUNCTION PHENOTYPES THAT FACILITATE SCREENING FOR SMALL MOLECULE MODULATORS OF PAK ACTIVITY IN THE NEMATODE, CAENORHABDITIS ELEGANS
#3515Preventive and/or Treating Agent for Cancer
#3516Method of predicting and reducing risk of metastasis of breast cancer to lung
#3517Compositions and methods for the targeted insertion of a nucleotide sequence of interest into the genome of a plant
#3518Methods and Compositions for Treating 5Alpha-Reductase Type 1 and Type 2 Dependent Conditions
#3519Method For Preventing or Treating Pain in a Mammal
#3520Antisense modulation of p38 mitogen activated protein kinase expression
#3521siRNA targeting human hairless protein (HR)
#3522siRNA targeting DNA-damage-inducible transcript 4 (DDIT4)
#3523RNA interference mediated inhibition of hypoxia inducible factor 1 (HIF1) gene expression using short interfering nucleic acid (siNA)
#3524ANTISENSE MODULATION OF ACYL COA CHOLESTEROL ACYLTRANSFERASE-2 EXPRESSION
#3525OLIGORIBONUCLEOTIDES FOR THE TREATMENT OF DEGENERATIVE SKIN CONDITIONS BY RNA INTERFERENCE
#3526siRNA targeting cyclin-dependent kinase inhibitor 1B (p27, Kip1) (CDKN1B)
#3527Allele-specific silencing of disease genes
#35282′-arabino-fluorooligonucleotide N3′-P5′ phosphoramidates: their synthesis and use
#3529Oligonucleotide-containing pharmacological compositions and their use
#3530Oligonucleotide-containing pharmacological compositions and their use
#3531Alpha-synuclein kinase
#3532Treatment of neurological disorders by dsRNA administration
#3533Antisense modulation of stearoyl-CoA desaturase expression
#3534COMPOSITIONS AND METHODS FOR siRNA INHIBITION OF ANGIOGENESIS
#3535Positionally modified siRNA constructs
#3536siRNA targeting myeloid cell leukemia sequence 1
#3537CASPASE-8 INTERACTING PROTEINS
#3538Recombinant adeno-associated virus expressing human antisense gene CyP2J2 and its preparation methods
#3539Methods for Chk2 inhibitor patient selection
#3540Bead based receptor biology
#3541Clusterin antisense therapy for treatment of cancer
#3542Functional and hyperfunctional siRNA directed against Bcl-2
#3543Casein kinase 2 antisense therapy
#3544Compositions and methods for inhibiting expression of the PCSK9 gene
#3545Functional and hyperfunctional siRNA directed against Bcl-2
#3546Functional and hyperfunctional siRNA directed against Bcl-2
#3547Compositions and methods for inhibiting expression of IKK-B gene
#3548Midkine inhibitory compositions for the treatment of angiostenosis
#3549Functional and hyperfunctional siRNA directed against Bcl-2
#3550Kinase suppressor of Ras inactivation for therapy of Ras mediated tumorigenesis
#3551Animal models for demyelination disorders
#3552BGL3 beta-glucosidase and nucleic acids encoding the same
#3553GENES FOR MICROSOMAL DELTA-12 FATTY ACID DESATURASES AND RELATED ENZYMES FROM PLANTS
#3554Functional and hyperfunctional siRNA directed against Bcl-2
#3555Functional and hyperfunctional siRNA directed against Bcl-2
#3556Functional and hyperfunctional siRNA directed against Bcl-2
#3557Functional and hyperfunctional siRNA directed against Bcl-2
#3558EML4-ALK fusion gene
#3559Antagonist of TEB4 and Methods of Use
#3560INHIBITION OF EXPRESSION OF A TARGET GENE
#3561Genes For Microsomal Delta-12 Fatty Acid Desaturases And Hydroxylases From Plants
#3562pRNA chimera
#3563Modulators of pharmacological agents
#3564Method for inhibiting NOX1 gene expression
#3565Peptide-Pna Chimera Targeting Inducible Nitric Oxide Synthetase
#3566Silencing RNA molecules and their use in bone formation
#3567Treatment Of Neurodegenerative Diseases By The Use Of Laptm4a
#3568Materials and Methods Relating to Cell Cycle Control
#3569RNA interference mediated inhibition of aurorakinase B and its combinations as anticancer therapy
#3570Polycationic compositions for cellular delivery of polynucleotides
#35712'-MODIFIED OLIGONUCLEOTIDES
#3572RNA interference mediated treatment of Alzheimer's disease using short interfering nucleic acid (siNA)
#3573Method for treating an immune disorder by decreasing NIK-SIVA complex formation
#3574Cell-based RNA interference and related methods and compositions
#3575Multicistronic constructs with siRNA to inhibit tumors
#3576Short antisense compounds with gapmer configuration
#3577Cochleate compositions directed against expression of proteins
#3578Antisense modulation of kinesin-like 1 expression
#3579Delivering functional nucleic acids to mammalian cells via bacterially-derived, intact minicells
#3580Treatment of Neurodegenerative Diseases by the Use of Degs Inhibitors
#3581Pharmaceutical Compositions and Methods for Reducing Body Fat
#3582Antibody that specifically binds hyaluronan synthase
#3583RNAI-mediated inhibition of tumor necrosis factor α-related conditions
#3584Compositions and methods for inhibiting expression of Eg5 gene
#3585Tie Receptor and Tie Ligand Materials and Methods for Modulating Female Fertility
#3586Treatment Of Neurodegenerative Diseases By The Use Of Atp7a
#3587RNA amidates and thioamidates for RNAi
#3588Therapeutic compositions
#3589Method of Inhibiting Secretase Activity
#3590Double-stranded ribonucleic acid with increased effectiveness in an organism
#3591THERAPEUTIC DRUG COMBINATIONS AND DELIVERY SYSTEMS COMPRISING C-RAF KINASE ANTISENSE POLYNUCLEOTIDES FOR TREATING OCULAR DISEASES AND DISORDERS
#3592Antisense Oligonucleotides Directed to Ribonucleotide Reductase R1 and Uses Thereof in the Treatment of Cancer
#3593Oligonucleotide and the use thereof for modulating an isoform C beta-1 protein-kinase in the form of a skin depigmentation agent
#3594Treatment of eye disorders characterized by an elevated intraocular pressure by siRNAs
#3595Modulation of telomere length by oligonucleotides having a G-core sequence
#3596Use of Caspase-8 Inhibitors for Modulating Hematopoiesis
#3597Non-immunogenic, hydrophilic/cationic block copolymers and uses thereof
#3598Compositions and methods for enhancing discriminatory RNA interference
#3599Identification and use of target genes for control of plant parasitic nematodes
#3600Modulators of CDC2-like kinases (CLKS) and methods of use thereof